Ichnos Glenmark Innovation

News

AbbVie cuts $1.9bn+ deal with IGI for trispecific antibody

AbbVie has signed another deal in its effort to build an industry-leading position in multispecific antibodies for blood cancers.

R&D

Is this the year for precision psychology? With Amit Etkin

At the Sachs Neuroscience Forum just before the start of JPM 2026 in San Francisco, pharmaphorum spoke with Amit Etkin, CEO of Alto Neuroscience.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Sales & Marketing

Physicians walking and using tablet devices

How to meet your physicians where they are online

A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.

Ichnos Glenmark Innovation

Editor's Picks